{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:05:55Z","timestamp":1766088355368,"version":"3.48.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This study aim to elucidate the mechanistic role of secretin receptor (SCTR) in pancreatic ductal adenocarcinoma (PDAC) pathogenesis by systematically characterizing its alternative splicing (AS) landscape.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study systematically investigated the specific gene expression profiles of PDAC by integrating multi-omics data from TCGA and GTEx public databases. We collected formalin-fixed paraffin-embedded (FFPE) specimens and clinicopathologic data from 65 PDAC patients. Immunohistochemical (IHC) analysis was performed to determine the differential expression of secretin receptor (SCTR) between PDAC and adjacent nontumor (ATN) tissues, along with its clinicopathologic correlations. RNA sequencing (RNA-seq) was conducted on 9 paired PDAC and ATN samples, followed by alternative splicing (AS) analysis using rMATs software to identify prognostic-related splicing events. IHC validation confirmed the protein-level expression patterns. Notably, through RT-qPCR and cloning\/sequencing approaches, we unexpectedly discovered an intron 2-retained alternative splicing variant of SCTR, which may represent a novel PDAC-specific isoform.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Public data shows that compared with other tissues, SCTR expression in pancreatic tissue and pancreatic cancer is higher, and SCTR expression in pancreatic cancer is lower (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). In pancreatic cancer, the high expression of SCTR is associated with better overall survival (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.01). IHC expression analysis of 65 PDAC retrospective samples showed that the expression of SCTR protein in PDAC was significantly lower than that of ATN (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001), and the expression of SCTR protein was correlated with distant metastasis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05), tumor stage (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001) and Ki67 expression (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05) in PDAC.The RNA-seq results of this study showed that in 6 groups of samples, the expression of SCTR in PDAC was lower than that in ATN, with 5 groups significantly down regulated (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05). RNA-seq sequencing revealed 18 alternative splicing patterns of SCTR in PDAC and ATN, among which the number of 3 high-frequency alternative splicing events, namely exon 9 skipping, fragments of intron 2 retention, and alternative 3\u2019 splice site of exon 3, were differed among multiple pairs of PDAC and ATN samples (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05) (\u22653 groups). Simultaneously, it was found that SNP rs2587682 (c.194-1804 T&gt;C) and the fragments of intron 2 retention of SCTR were associated with the occurrence of this alternative splicing event (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.01). RT-qPCR and cloning sequencing results verified the existence of alternative splicing, the retained fragment is located in intron 2 between exons 2 and 3 of SCTR, and the sequence is 114bp. The expression of intron 2 of SCTR in ATN (2.58\u00b14.41) was higher than that in PDAC (0.16\u00b10.12) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Moreover, the expression of intron 2 of SCTR in samples with genotype GG of rs2587682 (2.42\u00b11.61) was significantly higher than that in samples with genotype AA (1.01\u00b10.20) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This study provides novel insights into identifying potential therapeutic targets for pancreatic cancer, highlighting that SCTR may serve as a promising prognostic and diagnostic biomarker, with its low expression significantly associated with poor clinical outcomes in PDAC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mpa.0000000000002569","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T15:05:29Z","timestamp":1758207929000},"page":"e41-e51","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Alternative Splicing of Secretin Receptor (SCTR) and Its Low Expression Drive the Occurrence of Pancreatic Ductal Adenocarcinoma"],"prefix":"10.1097","volume":"55","author":[{"given":"Yanqi","family":"Ke","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qicai","family":"Liu","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Centre, The First Affiliated Hospital, Fujian Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Department of Pathology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fujian, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,1]]},"reference":[{"key":"R1-20251218","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1101\/gad.338962.120","article-title":"Alternative splicing and cancer: insights, opportunities, and challenges from an expanding view of the transcriptome","volume":"34","author":"Cherry","year":"2020","journal-title":"Genes Dev"},{"key":"R2-20251218","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00439-017-1790-y","article-title":"Alternative splicing: the pledge, the turn, and the prestige: The key role of alternative splicing in human biological systems","volume":"136","author":"Gallego-Paez","year":"2017","journal-title":"Hum Genet"},{"key":"R3-20251218","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","article-title":"Roles and mechanisms of alternative splicing in cancer-implications for care","volume":"17","author":"Bonnal","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"R4-20251218","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.hoc.2015.04.003","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"29","author":"Dunne","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"R5-20251218","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R6-20251218","doi-asserted-by":"crossref","first-page":"522383","DOI":"10.3389\/fgene.2020.522383","article-title":"Survival-associated alternative splicing events and prognostic signatures in pancreatic cancer","volume":"11","author":"Xu","year":"2020","journal-title":"Front Genet"},{"key":"R7-20251218","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.7150\/thno.42795","article-title":"The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy","volume":"10","author":"Guo","year":"2020","journal-title":"Theranostics"},{"key":"R8-20251218","first-page":"1583","article-title":"Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14. 2 in pancreatic carcinoma cell lines","volume":"58","author":"Simon","year":"1998","journal-title":"Cancer Res"},{"key":"R9-20251218","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0002-9440(10)61186-8","article-title":"Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia","volume":"167","author":"Korner","year":"2005","journal-title":"Am J Pathol"},{"key":"R10-20251218","first-page":"5223","article-title":"Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma","volume":"62","author":"Ding","year":"2002","journal-title":"Cancer Res"},{"key":"R11-20251218","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0016-5085(98)70491-3","article-title":"Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors","volume":"114","author":"Ulrich","year":"1998","journal-title":"Gastroenterology"},{"key":"R12-20251218","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/biomedicines10030536","article-title":"Secretin receptor as a target in gastrointestinal cancer: expression analysis and ligand development","volume":"10","author":"Klussmeier","year":"2022","journal-title":"Biomedicines"},{"key":"R14-20251218","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J"},{"key":"R15-20251218","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"key":"R16-20251218","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general-purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"R17-20251218","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-Seq","volume":"5","author":"Mortazavi","year":"2008","journal-title":"Nature Method"},{"key":"R18-20251218","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"R19-20251218","doi-asserted-by":"crossref","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","article-title":"rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data","volume":"111","author":"Shen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-20251218","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0002-9440(10)61186-8","article-title":"Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia","volume":"167","author":"Korner","year":"2005","journal-title":"Am J Pathol"},{"key":"R21-20251218","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2353\/ajpath.2009.081135","article-title":"Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors","volume":"175","author":"K\u00f6rner","year":"2009","journal-title":"Am J Pathol"},{"key":"R22-20251218","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1074\/mcp.M700590-MCP200","article-title":"Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis","volume":"7","author":"Thorsen","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"R23-20251218","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MPA.0b013e31820128d2","article-title":"Characterization of alternative spliceoforms and the RNA splicing machinery in pancreatic cancer","volume":"40","author":"Carrigan","year":"2011","journal-title":"Pancreas"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:01:04Z","timestamp":1766088064000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000002569","relation":{},"ISSN":["1536-4828"],"issn-type":[{"type":"electronic","value":"1536-4828"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"2025-05-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}